Document is current
Any future updates will be listed below
-
Authors
Kim, David https://orcid.org/0000-0002-7593-6052
Vanderbilt, Chad M. https://orcid.org/0000-0002-8114-0237
Yang, Soo-Ryum
Nandakumar, Subhiksha
Nafa, Khedoudja
Feratovic, Rusmir
Rekhtman, Natasha
Rijo, Ivelise
Casanova, Jacklyn https://orcid.org/0000-0002-3586-7048
Yun, Anita
Brannon, A. Rose https://orcid.org/0000-0003-4610-0149
Berger, Michael F. https://orcid.org/0000-0003-3882-5000
Ladanyi, Marc https://orcid.org/0000-0001-9055-7213
Lin, Oscar
Arcila, Maria E. https://orcid.org/0000-0001-5824-6554
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748)
- License Information
-
More Information
Article History
Received: 15 July 2024
Accepted: 3 December 2024
First Online: 2 January 2025
Competing interests
: C.V. reports intellectual property rights and equity interest in Paige.AI, Inc. A.R.B. has ownership/equity interests in Johnson and Johnson. M.B. has received advisory or consulting fees from AstraZeneca, Eli Lilly and Company, and PetDx, Inc. M.L. has received advisory or consulting fees from Takeda Oncology, Janssen Pharmaceuticals, AstraZeneca, ADC Therapeutics, Paige.AI, Merck, Bayer, and Lilly Oncology and has received research funding from Loxo Oncology, Helsinn Therapeutics, Merus NV, Elevation Oncology, and Rain Therapeutics. O.L. has received advisory or consulting fees from Hologic and Janssen Research & Development, LLC. M.A. has received advisory or consulting fees from Axis Medical Education, Clinical Education Alliance, LLC, Merck Sharp & Dohme, PeerView Institute for Medical Education (PVI), Physicians’ Education Resource, RMEI Medical Education, LLC, and Roche. The following Authors declare no competing interests: D.K., S.Y., S.N., K.N., R.F., N.R., I.R., J.C., and A.Y.
